Lexaria Bioscience - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi LEXX
Lexaria Bioscience (LEXX) reports a base operating result before depreciation that demonstrates efficiency dynamics, with the value stabilizing at 0.00. Margin resilience is supported by DehydraTECH patents, which create a significant barrier to entry for competitors. Growth potential is linked to the implementation of delivery systems for anti-obesity drugs; however, international licensing is complicated by geopolitical tensions and regulatory disputes regarding intellectual property protection.
Ringkesan rincian data analitis Lexaria Bioscience Corp. (LEXX)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Lexaria Bioscience|LEXX - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Lexaria Bioscience Corp|LEXX - Gunggung utang perusahaan|Utang-utang marang nilai buku Lexaria Bioscience|LEXX - Kewajiban jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Lexaria Bioscience|Rasio cepet lexariabioscience.com
- statistik bathi lan rasio pasar:
LEXX - Bathi resik perusahaan|Penghasilan resik sing dikarepake Lexaria Bioscience|LEXX - Pangali P/E|Kapitalisasi marang proyeksi bathi Lexaria Bioscience Corp|LEXX - Pangali PEG|Pangali EV/EBITDA Lexaria Bioscience|LEXX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Lexaria Bioscience|LEXX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan lexariabioscience.com|LEXX - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Lexaria Bioscience
Ringkesan analitik perusahaan:Lexaria Bioscience
For Lexaria Bioscience (LEXX), which utilizes outsourced manufacturing and strict biosafety regulations, the EBITDA trend visualization reflects the actual cash flow from the commercialization of bioavailability technologies. This indicator excludes non-cash depreciation and amortization charges, allowing investors to assess the actual operational efficiency of the business; an upward curve confirms the company's ability to generate liquidity, while a decline signals a critical increase in costs.
Analisis pesaing Lexaria Bioscience
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharmaceuticals Incorporated - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Perrigo Corp PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech (ALVO)|LQDA (liquidia.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Galapagos GLPG|ANI Pharmaceuticals Inc - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MannKind Corp. - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Amphastar Corp|PCRX (Pacira BioSciences) - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge amortisasi SPRY|TBPH (Theravance Biopharma, Inc.) - Bathi operasional EBITDA|Bathi operasional EBITDA Aquestive Therapeutics Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TNXP (Tonix Pharmaceuticals)|Pendapatan operasional sadurunge ngurangi amortisasi SXT Pharmaceuticals (SXTC)|Eupraxia Pharma - Bathi operasional EBITDA|BHST - Bathi operasional EBITDA|EXOZ (Invizyne Technologies, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|Oramed Pharmaceuticals Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|ENTX (Entera Bio Ltd) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi HYFT|Bathi operasional EBITDA ABVC|Pendapatan operasional sadurunge ngurangi amortisasi Cumberland Pharmaceuticals Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Quantum BioPharma Limited QNTM|FibroGen Corporation (FGEN) - Bathi sadurunge bunga, pajak, lan amortisasi|TELO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Rani Therapeutics RANI|SNYR: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Rallybio|PULM (Pulmatrix Corp) - Bathi operasional EBITDA|Pheton (PTHL) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA APM|LYRA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Impact BioMedical IBO|TNFA: Bathi operasional sadurunge amortisasi|cbdMD Corp - Bathi operasional EBITDA|PainReform Corp (PRFX) - Bathi operasional sadurunge ngurangi amortisasi|CYTO: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi lipella.com (LIPO)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OptiNose|Bathi sadurunge mbayar bunga, pajak, lan amortisasi PIRS|Bathi operasional EBITDA PROC|PTPI - Bathi sadurunge bunga, pajak, lan amortisasi|Qilian International - Bathi operasional sadurunge ngurangi amortisasi|SLRN: Bathi operasional sadurunge amortisasi|TFFP: Bathi operasional sadurunge ngurangi amortisasi
